Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer.
Tumor-mutation burden is another predictive biomarker.
»
10/03/18
Detection of KK-LC-1 Protein, a Cancer/Testis Antigen, in Patients with Breast Cancer.
KK-LC-1 detected in all tumours without oestrogen receptor expression.
»
08/28/18
A novel small molecule inhibitor of MRCK prevents radiation-driven invasion in glioblastoma.
Treatment with BDP-9066 in combination with RT significantly increased survival.
»
09/17/18
External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
Treatment with EBRT independently associated with risk of developing second primary BCa.
»
04/18/18
CDK1 interacts with Sox2 and promotes tumor initiation in human melanoma.
Previously unrecognized role for CDK1 in regulating tumor-initiating capacity in melanoma.
»
09/25/18
Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer.
KLK4-7 clearly regulates expression of MSN, KRT19, KRT7 and JUNB.
»
04/24/18
Association between soluble immune mediators and tumor responses in patients with non-small cell lung cancer treated with anti-PD-1 inhibitor.
Changes maintained during course of anti-PD-1 therapy in patients who showed better clinical outcomes.
»
07/08/18
Up-regulation of Bone Morphogenetic Protein 7 by 2-Hydroxycinnamaldehyde Attenuates HNSCC Cell Invasion.
Suppression of BMP7 by siRNA alleviated inhibitory effect of HCA.
»
08/23/18
Methylation of the claudin‑3 promoter predicts the prognosis of advanced gastric adenocarcinoma.
Claudin‑3 promoter hypermethylation reduces claudin‑3 expression.
»
11/17/17
Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy.
High-throughput analysis of Cancer Genome Atlas data identified distinct targets.
»
06/22/18
< Prev
Next >